Phase I Study of RiMO-301 With Radiation in Advanced Tumors

NCT03444714 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Coordination Pharmaceuticals, Inc.

Collaborators